Yoshida T, Tanaka M, Okamoto K
Department of Neurology, Gunma University School of Medicine, Showa-machi, Maebashi, 371-8511, Gunma, Japan.
Neurosci Lett. 2001 Jan 5;297(1):5-8. doi: 10.1016/s0304-3940(00)01631-1.
We evaluated the effect of nicergoline on superoxide production by rat microglias using a 2-methyl-6-(p-methoxyphenyl)-3, 7-dihydroimidazo[1,2-a]pyrazin-3-one-dependent chemiluminescence assay. Nicergoline dose-dependently inhibited superoxide production by microglias stimulated with phorbol myristate acetate or opsonized zymosan, while it had no effect on superoxide production by a hypoxanthine-xanthine oxidase system. These results indicate that nicergoline does not have a scavenging effect, but has an inhibitory effect on superoxide generation by microglias. Although this drug is commonly used for treating chronic cerebral infarction, it may also have a protective effect on progression of Parkinson's disease or Alzheimer's disease.
我们使用一种依赖于2-甲基-6-(对甲氧基苯基)-3,7-二氢咪唑并[1,2-a]吡嗪-3-酮的化学发光测定法,评估了尼麦角林对大鼠小胶质细胞超氧化物生成的影响。尼麦角林剂量依赖性地抑制了由佛波醇肉豆蔻酸酯乙酸盐或调理酵母聚糖刺激的小胶质细胞的超氧化物生成,而对次黄嘌呤-黄嘌呤氧化酶系统的超氧化物生成没有影响。这些结果表明,尼麦角林没有清除作用,但对小胶质细胞的超氧化物生成具有抑制作用。尽管这种药物通常用于治疗慢性脑梗死,但它可能对帕金森病或阿尔茨海默病的进展也具有保护作用。